ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.990,31
0,44%
S&P 500
5.996,66
1,00%
Dow Jones
43.487,83
0,78%
Euro vs US Dollar
1,03899
-0,30%
Bitcoin
101.895,12
-0,12%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC

  6. Burzynski Research Institute (PK) (BZYR) Börsenkurse

Burzynski Research Institute (PK)

Burzynski Research Institute (PK) (BZYR)

USOTC
0,05
0,00
(0,00%)
Geschlossen 21 Januar 10:00PM
Verzögert um 15 Minuten

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
0,05
Gebot
0,03
Fragen
0,0598
Volumen
-
0,00 Tagesbereich 0,00
0,013 52-Wochen-Bereich 0,077
Marktkapitalisierung
6,572M
Handelsende
0,05
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
10.325
Ausgegebene Aktien
131.448.444
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-4,90
Gewinn pro Aktie (EPS)
-0,01
Erlöse
-
Nettogewinn
-1,34M

Über Burzynski Research Institute (PK)

Sektor
In Vitro,in Vivo Diagnostics
Branche
In Vitro,in Vivo Diagnostics
Website
www.burzynskiresearch.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Burzynski Research Institute (PK) is listed in the In Vitro,in Vivo Diagnostics sector of the OTCMarkets with ticker BZYR. The last closing price for Burzynski Research Insti... (PK) was US$0,05. Over the last year, Burzynski Research Insti... (PK) shares have traded in a share price range of US$ 0,013 to US$ 0,077.

Burzynski Research Insti... (PK) currently has 131.448.444 shares in issue. The market capitalisation of Burzynski Research Insti... (PK) is US$6,57 million. Burzynski Research Insti... (PK) has a price to earnings ratio (PE ratio) of -4.90.

BZYR Neueste Nachrichten

Weitere Nachrichten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 Januar 2025
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

10 Oktober 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

15 Juli 2024
Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

29 Mai 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

16 Januar 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 Oktober 2023
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 Juli 2023
Edgar (US Regulatory)

Burzynski Research Institute, Inc. Announces Publication of Phase II Results in Patients with Non-Diffuse Intrinsic Pontine G...

Burzynski Research Institute, Inc., a biopharmaceutical company dedicated to the development and commercialization of novel therapies for patients with brain and brainstem tumors and other...

17 April 2015
Business Wire

Burzynski Research Institute, Inc. Announces Publication of Phase II Results in Adults with Newly-Diagnosed Anaplastic Astroc...

Burzynski Research Institute, Inc., a biopharmaceutical company dedicated to the development and commercialization of novel therapies for patients with rare brain tumors and other cancers...

31 März 2015
Business Wire

Burzynski Research Institute, Inc. Announces Publication of Phase 2 Clinical Study in Metastatic Colon Adenocarcinoma of the ...

Burzynski Research Institute, Inc. Announces Publication of Phase 2 Clinical Study in Metastatic Colon Adenocarcinoma of the Liver PR Newswire HOUSTON, March 26, 2015 HOUSTON, March 26, 2015...

26 März 2015
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0095123.48728081010.040490.050.040495000.045245CS
4000.050.050.03145600.04629634CS
120.00819.04761904760.0420.05450.031103250.04085009CS
260.00819.04761904760.0420.0770.031223400.05414821CS
52-0.00205-3.938520653220.052050.0770.013162420.04674988CS
1560.0266.66666666670.030.15750.013289350.04216942CS
2600.0369281.6793893130.01310.15750.0061230540.03806995CS

BZYR - Frequently Asked Questions (FAQ)

What is the current Burzynski Research Insti... (PK) share price?
The current share price of Burzynski Research Insti... (PK) is US$ 0,05
How many Burzynski Research Insti... (PK) shares are in issue?
Burzynski Research Insti... (PK) has 131.448.444 shares in issue
What is the market cap of Burzynski Research Insti... (PK)?
The market capitalisation of Burzynski Research Insti... (PK) is USD 6,57M
What is the 1 year trading range for Burzynski Research Insti... (PK) share price?
Burzynski Research Insti... (PK) has traded in the range of US$ 0,013 to US$ 0,077 during the past year
What is the PE ratio of Burzynski Research Insti... (PK)?
The price to earnings ratio of Burzynski Research Insti... (PK) is -4,9
What is the reporting currency for Burzynski Research Insti... (PK)?
Burzynski Research Insti... (PK) reports financial results in USD
What is the latest annual profit for Burzynski Research Insti... (PK)?
The latest annual profit of Burzynski Research Insti... (PK) is USD -1,34M
What is the registered address of Burzynski Research Insti... (PK)?
The registered address for Burzynski Research Insti... (PK) is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Burzynski Research Insti... (PK) website address?
The website address for Burzynski Research Insti... (PK) is www.burzynskiresearch.com
Which industry sector does Burzynski Research Insti... (PK) operate in?
Burzynski Research Insti... (PK) operates in the IN VITRO,IN VIVO DIAGNOSTICS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TMGIMarquie Group Inc (PK)
US$ 0,0002
(19.900,00%)
4,03M
SEANSAEAN Group Inc (PK)
US$ 1,87
(18.600,00%)
100
ZPASZoompass Holdings Inc (CE)
US$ 0,0001
(9.900,00%)
675
GMPRGourmet Provisions International Corporation (PK)
US$ 0,0001
(9.900,00%)
35,31M
PLPLPlandai Biotechnology Inc (PK)
US$ 0,0001
(9.900,00%)
18,06M
STNXStartronix International Inc (CE)
US$ 0,000001
(-99,99%)
450
AWINAERWINS Technologies Inc (CE)
US$ 0,000001
(-99,97%)
2,03k
ISOLImage Software Inc (CE)
US$ 0,000001
(-99,91%)
59,2k
NBIONascent Biotech Inc (CE)
US$ 0,0002
(-99,55%)
8,7k
FHBCFernhill Beverage Inc (CE)
US$ 0,000001
(-99,24%)
10k
GTCHGBT Technologies Inc (PK)
US$ 0,0001
(0,00%)
349,77M
VTXBVortex Brands Company (PK)
US$ 0,0002
(0,00%)
297,52M
EMEDElectroMedical Technologies Inc (PK)
US$ 0,0002
(0,00%)
233,53M
PHILPHI Group Inc (PK)
US$ 0,0002
(-33,33%)
184,12M
HMBLHUMBL Inc (PK)
US$ 0,0009
(-5,26%)
179,2M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

USOTC
BZYR
Burzynski Research Insti... (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten